Skip to main content
News & Events

Genesis Research Group and COS announce innovative partnership

By July 15, 2022November 11th, 2023No Comments

OS graphicWe are delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS).

As the regulatory landscape with respect to RWE continues to evolve, this innovative partnership brings together COS’s Clinical Outcomes Assessment scientific and clinical trial expertise and the evidence-based expertise of Genesis Research Group – keeping both companies firmly at the forefront of this ever-changing landscape to the wider benefit of clients, payers, and regulators.

Established in 2013, COS is a global leader in delivering innovative science to capture and communicate the patient voice, in order to provide actionable evidence in clinical drug development through qualitative and quantitative research, with a specific focus on Clinical Outcomes Assessments.

Genesis Research Group is an international RWE and HEOR organization that delivers scientifically rigorous, tech-enabled solutions to pharmaceutical, biotech, and medical device clients across the product lifecycle.

stacie hudgensStacie Hudgens, Chief Executive Officer at Clinical Outcomes Solutions, said:
“Clinical Outcomes Solutions was founded in 2013 with a specific focus on bringing innovative scientific solutions to patient-centered research. Our longstanding relationship with Genesis Research Group transitioning to a scientific partnership with the Oncology Outcomes network of partners continues to expand that focus.

“Evidence generation of patient-centered outcomes begins with prospective and clinical studies and expands through real-world treatment experience and symptoms management. This partnership, along with the additional Oncology Outcomes partners, provides Life Sciences Companies (LSCs) with a comprehensive body of evidence to support new anti-cancer therapy clinical development programs.”

chris pashosChris Pashos, Member, Board of Directors, Genesis Research Group, said:
“Regulatory bodies around the world have made Real-World Evidence and Clinical Outcomes Assessments central to their consideration of new therapies developed by Life Sciences Companies. This partnership offers LSCs the combined capabilities of leaders in these areas. Together the partnership can ensure that LSCs develop and execute timely strategies that will meet the evidentiary requirements of regulators.”

tara symondsTara Symonds, Chief Science Officer at Clinical Outcomes Solutions, said:
“Real-world studies to capture patient-centred effectiveness data require careful design, implementation and analysis given the often-uncontrolled nature of the study design. Bringing together our organizations – and with this our respective skillsets and proven expertise – will provide an industry-leading offering for Life Sciences Companies to leverage, especially given the increasing interest and request for such data by both regulators and payers.”

Further information:

About Clinical Outcome Solutions
Clinical Outcomes Solutions, founded in 2013, is a solution-focused team with global experience committed to bringing together the right team of experts to approach medical research questions. The expert team provides clients with the most effective clinical outcome solution to help make the right patient care value decisions. COS has expertise in qualitative and quantitative research that will result in actionable evidence to support clinical and regulatory strategies for both the US and European markets. For more information, please visit

About Genesis Research Group
Genesis Research Group is an international Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) research organization that supports the life sciences industry. As a leader in evidence strategy, generation and communication, the company also supports pharmaceutical and biotech clients with tech-enabled, dedicated partnerships delivered via a unique engagement model that enables life sciences companies to address complex needs with unmatched timeliness and quality. For more information, visit more information, please contact:

Genesis Research Group: Richard Chumbley (

Clinical Outcomes Solutions: Clare Grove (


111 River Street, Suite 1120
Hoboken, New Jersey 07030, US